Mr. Willie Frank Furr, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 849 S Three Notch St, Andalusia, AL 36420 Phone: 334-222-8466 Fax: 334-222-9811 |
Michelle L Thomason, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 849 S Three Notch St, Andalusia, AL 36420 Phone: 334-222-8466 Fax: 334-222-9811 |
Mr. Jeffrey Lynn Ruthford, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 849 S Three Notch St, Andalusia, AL 36420 Phone: 334-222-8466 Fax: 334-222-9811 |
Ms. Carmelita M Day, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 11345 Brooklyn Rd, Andalusia, AL 36421 Phone: 334-427-1021 Fax: 334-427-3021 |
News Archive
Remdesivir is an antiviral first developed by Gilead in 2014 as a treatment for Ebola and Marburg viruses. However, scientists explored its possibilities as a broad-spectrum drug when it proved effective against SARS-CoV and MERS-CoV, coronaviruses which were responsible for earlier outbreaks.
To mark World Polio Day, the New York Times' "India Ink" blog features an interview with Naveen Thacker, a member of the team that led India's polio eradication efforts. The country has not recorded a new case of polio since January 2011 and is in line to be declared polio-free in January 2014 if no new cases occur, according to the blog.
A National Eye Institute (NEI) study has found that although 94 percent of Americans aged 12 and older have good vision, the remaining six percent, or 14 million, are visually impaired.
US Oncology, Inc., the leading oncology services company uniting the nation's largest cancer treatment and research network to expand patient access to high-quality, cost-effective cancer care and advance the science of cancer care, has been named to FORTUNE magazine's World's Most Admired Companies list for 2010.
CardioNet, Inc., a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the first quarter-ended March 31, 2012.
› Verified 4 days ago